741 Reductions in A1C were also greater with liraglutide 3 mg (-1.3%) compared to liraglutide 1.8 mg (-1.1%) and placebo (0.3%)
Recently, Ozempic has also gained attention for its use in weight loss, although its primary purpose remains blood sugar control
The slow titration schedule, starting at 0.25 mg and escalating gradually to 2.4 mg, is specifically designed to minimize these effects by giving the body time to adapt
Some people use both, but combination therapy requires monitoring for digestive symptoms, hydration, glucose patterns, and interactions with other diabetes medicines
This means oral medications are released into the body with the same delay
The overall feeling on semaglutide and tirzepatide improves significantly as the body adapts